NPCE
NeuroPace Inc
+0.02 (+0.14%)14.12USD41.7K成交股數485M市值–本益比(近四季)4.7股價營收比+17.1%營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 09-04 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.3K | 14.75 | 19K | 138K | SEC |
| 2026-08-27 | 08-28 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 358 | 14.13 | 5K | 51.7K | SEC |
| 2026-08-27 | 08-28 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.1K | 14.13 | 16K | 139K | SEC |
| 2026-06-24 | 06-25 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 335 | 16.22 | 5K | 52.0K | SEC |
| 2026-06-19 | 06-22 | Geiger Uri | Director | A 獲配股票 | 789 | 15.63 | 12K | 18.5K | SEC |
| 2026-06-19 | 06-22 | Kumar Rakhi | Director | A 獲配股票 | 989 | 15.63 | 15K | 23.0K | SEC |
| 2026-06-19 | 06-22 | Fischer Frank M | Director | A 獲配股票 | 1.5K | 15.63 | 23K | 600K | SEC |
| 2026-06-05 | 06-05 | Kumar Rakhi | Director | A 獲配股票 | 2.9K | – | – | 22.1K | SEC |
| 2026-06-05 | 06-05 | Fischer Frank M | Director | A 獲配股票 | 2.9K | – | – | 598K | SEC |
| 2026-06-05 | 06-05 | Huennekens R Scott | Director | A 獲配股票 | 2.9K | – | – | 2.9K | SEC |
| 2026-06-05 | 06-05 | Ryan Renee | Director | A 獲配股票 | 2.9K | – | – | 2.9K | SEC |
| 2026-06-05 | 06-05 | Geiger Uri | Director | A 獲配股票 | 2.9K | – | – | 17.7K | SEC |
| 2026-06-05 | 06-05 | Andrade Lisa | Director | A 獲配股票 | 2.9K | – | – | 2.9K | SEC |
| 2026-06-03 | 06-04 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.3K | 15.88 | 20K | 140K | SEC |
| 2026-05-27 | 05-28 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.1K | 17.06 | 19K | 142K | SEC |
| 2026-05-27 | 05-28 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 358 | 17.06 | 6K | 52.4K | SEC |
| 2026-05-15 | 05-19 | Becker Joel | CHIEF EXECUTIVE OFFICER | A 獲配股票 | 45.9K | – | – | 143K | SEC |
| 2026-05-15 | 05-19 | Williams Patrick F. | Chief Financial Officer | A 獲配股票 | 16.8K | – | – | 68.7K | SEC |
| 2026-05-15 | 05-19 | Morrell Martha | CHIEF MEDICAL OFFICER | A 獲配股票 | 5.5K | – | – | 52.7K | SEC |
| 2026-03-24 | 03-25 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.3K | 13.27 | 18K | 47.3K | SEC |
| 2026-03-20 | 03-24 | Geiger Uri | Director | A 獲配股票 | 913 | 13.00 | 12K | 14.9K | SEC |
| 2026-03-20 | 03-24 | LACOB JOSEPH | Director | A 獲配股票 | 865 | 13.00 | 11K | 14.8K | SEC |
| 2026-03-20 | 03-23 | Fischer Frank M | Director | A 獲配股票 | 1.8K | 13.00 | 24K | 595K | SEC |
| 2026-03-20 | 03-23 | Kumar Rakhi | Director | A 獲配股票 | 1.2K | 13.00 | 15K | 19.2K | SEC |
| 2026-03-03 | 03-04 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.3K | 13.83 | 19K | 48.6K | SEC |
| 2026-03-03 | 03-04 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 5.0K | 13.83 | 69K | 96.9K | SEC |
| 2026-02-27 | 03-02 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 358 | 14.58 | 5K | 75.0K | SEC |
| 2026-02-27 | 03-02 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.1K | 14.58 | 16K | 102K | SEC |
| 2026-02-20 | 02-23 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 3.4K | 14.34 | 49K | 75.3K | SEC |
| 2025-12-19 | 12-23 | Fischer Frank M | Director | A 獲配股票 | 1.4K | 16.59 | 24K | 593K | SEC |
| 2025-12-19 | 12-23 | LACOB JOSEPH | Director | A 獲配股票 | 678 | 16.59 | 11K | 13.9K | SEC |
| 2025-12-19 | 12-23 | Kumar Rakhi | Director | A 獲配股票 | 904 | 16.59 | 15K | 18.0K | SEC |
| 2025-12-19 | 12-23 | Geiger Uri | Director | A 獲配股票 | 715 | 16.59 | 12K | 13.9K | SEC |
| 2025-12-15 | 03-04 | Morrell Martha | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 25.0K | 15.97 | 399K | 50.0K | SEC |
| 2025-12-03 | 12-04 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.3K | 16.66 | 22K | 78.7K | SEC |
| 2025-11-27 | 12-01 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.1K | 16.50 | 19K | 103K | SEC |
| 2025-11-27 | 12-01 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 357 | 16.50 | 6K | 80.1K | SEC |
| 2025-11-20 | 11-24 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 3.1K | 13.50 | 41K | 80.4K | SEC |
| 2025-09-19 | 09-22 | LACOB JOSEPH | Director | A 獲配股票 | 1.1K | 9.94 | 11K | 13.2K | SEC |
| 2025-09-19 | 09-22 | Fischer Frank M | Director | A 獲配股票 | 2.4K | 9.94 | 24K | 592K | SEC |
| 2025-09-19 | 09-22 | Kumar Rakhi | Director | A 獲配股票 | 1.5K | 9.94 | 15K | 17.1K | SEC |
| 2025-09-19 | 09-22 | Geiger Uri | Director | A 獲配股票 | 1.2K | 9.94 | 12K | 13.2K | SEC |
| 2025-09-03 | 09-04 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.3K | 9.36 | 13K | 83.5K | SEC |
| 2025-08-27 | 08-28 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 357 | 8.88 | 3K | 84.8K | SEC |
| 2025-08-27 | 08-28 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.1K | 8.88 | 10K | 104K | SEC |
| 2025-08-20 | 08-22 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 3.1K | 8.66 | 26K | 85.2K | SEC |
| 2025-06-21 | 06-24 | LACOB JOSEPH | Director | A 獲配股票 | 1.1K | 10.41 | 11K | 12.1K | SEC |
| 2025-06-21 | 06-24 | Fischer Frank M | Director | A 獲配股票 | 2.3K | 10.41 | 24K | 590K | SEC |
| 2025-06-21 | 06-24 | Geiger Uri | Director | A 獲配股票 | 1.1K | 10.41 | 12K | 12.0K | SEC |
| 2025-06-21 | 06-24 | Kumar Rakhi | Director | A 獲配股票 | 1.4K | 10.41 | 15K | 15.6K | SEC |
| 2025-06-20 | 06-24 | Williams Patrick F. | Chief Financial Officer | A 獲配股票 | 51.9K | – | – | 51.9K | SEC |
| 2025-06-03 | 06-06 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 1.3K | 13.54 | 18K | 132K | SEC |
| 2025-06-03 | 06-06 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.3K | 13.54 | 18K | 85.9K | SEC |
| 2025-05-27 | 05-29 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 357 | 12.66 | 5K | 87.3K | SEC |
| 2025-05-27 | 05-29 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 357 | 12.66 | 5K | 133K | SEC |
| 2025-05-27 | 05-29 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 1.1K | 12.66 | 14K | 105K | SEC |
| 2025-05-20 | 05-21 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 3.1K | 17.99 | 55K | 133K | SEC |
| 2025-05-20 | 05-21 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 3.1K | 17.99 | 55K | 87.6K | SEC |
| 2025-05-14 | 05-16 | OrbiMed Capital GP VI LLC | TenPercentOwner | S 公開市場賣出 | 34.0K | 15.94 | 542K | 3.2M | SEC |
| 2025-05-14 | 05-16 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 134K | 15.83 | 2.1M | 3.3M | SEC |
| 2025-05-14 | 05-16 | OrbiMed Capital GP VI LLC | TenPercentOwner | S 公開市場賣出 | 134K | 15.83 | 2.1M | 3.3M | SEC |
| 2025-05-14 | 05-16 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 34.0K | 15.94 | 542K | 3.2M | SEC |
| 2025-04-22 | 04-23 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 237 | 10.94 | 3K | 90.7K | SEC |
| 2025-04-22 | 04-23 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 237 | 10.94 | 3K | 136K | SEC |
| 2025-03-24 | 03-24 | Morrell Martha | CHIEF MEDICAL OFFICER | A 獲配股票 | 11.7K | – | – | 90.9K | SEC |
| 2025-03-21 | 06-24 | Kumar Rakhi | Director | A 獲配股票 | 1.2K | 12.02 | 15K | 14.2K | SEC |
| 2025-03-21 | 06-24 | Fischer Frank M | Director | A 獲配股票 | 2.0K | 12.02 | 24K | 587K | SEC |
| 2025-03-21 | 06-24 | LACOB JOSEPH | Director | A 獲配股票 | 935 | 12.02 | 11K | 11.0K | SEC |
| 2025-03-21 | 06-24 | Geiger Uri | Director | A 獲配股票 | 987 | 12.02 | 12K | 10.9K | SEC |
| 2025-03-10 | 03-20 | Becker Joel | CHIEF EXECUTIVE OFFICER | A 獲配股票 | 58.5K | – | – | 106K | SEC |
| 2025-03-10 | 03-20 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | A 獲配股票 | 11.7K | – | – | 137K | SEC |
| 2025-03-03 | 03-05 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.3K | 11.81 | 16K | 79.2K | SEC |
| 2025-03-03 | 03-05 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 1.3K | 11.81 | 16K | 125K | SEC |
| 2025-02-27 | 03-20 | Becker Joel | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 4.5K | 12.56 | 57K | 48.0K | SEC |
| 2025-02-27 | 03-03 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.4K | 12.56 | 18K | 80.6K | SEC |
| 2025-02-27 | 03-03 | Kuhn Rebecca | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 1.4K | 12.56 | 18K | 126K | SEC |
| 2025-02-21 | 02-25 | Morrell Martha | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 78.3K | 13.72 | 1.1M | 82.0K | SEC |
| 2025-02-20 | 02-25 | Kuhn Rebecca | Chief Financial Officer | F 繳稅扣股 | 3.4K | 14.23 | 48K | 128K | SEC |
| 2025-02-20 | 02-25 | Morrell Martha | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 3.4K | 14.23 | 48K | 43.7K | SEC |
| 2025-02-20 | 02-20 | KCK LTD. | TenPercentOwner | S 公開市場賣出 | 5.3M | 9.40 | 49.5M | 0 | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Polar Capital Holdings Plc | 3.3M | 52.4M | 不變 | 持平 |
| Soleus Capital Management, L.P. | 2.9M | 46.3M | −21.1K (-1%) | 減碼 |
| First Light Asset Management, LLC | 2.9M | 45.5M | +401K (+16%) | 加碼 |
| MORGAN STANLEY | 2.7M | 42.2M | +87.6K (+3%) | 加碼 |
| BlackRock, Inc. | 2.5M | 39.4M | +131K (+6%) | 加碼 |
| ORBIMED ADVISORS LLC | 1.5M | 23.9M | −591K (-28%) | 減碼 |
| Driehaus Capital Management LLC | 1.4M | 23.0M | −4.2K (-0%) | 減碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | 19.5M | +103K (+9%) | 加碼 |
| DEUTSCHE BANK AG\ | 939K | 14.9M | +6.8K (+1%) | 加碼 |
| ARMISTICE CAPITAL, LLC | 692K | 11.0M | 不變 | 持平 |
| GEODE CAPITAL MANAGEMENT, LLC | 666K | 10.6M | +48.2K (+8%) | 加碼 |
| FMR LLC | 555K | 8.8M | +1.2K (+0%) | 加碼 |
| STATE STREET CORP | 550K | 8.7M | +52.6K (+11%) | 加碼 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 344K | 5.5M | −15.9K (-4%) | 減碼 |
| NORTHERN TRUST CORP | 260K | 4.1M | +20.2K (+8%) | 加碼 |
| Qube Research & Technologies Ltd | 221K | 3.5M | +35.0K (+19%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 220K | 3.5M | +32.9K (+18%) | 加碼 |
| Palumbo Wealth Management LLC | 209K | 3.3M | −1.3K (-1%) | 減碼 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209K | 3.3M | −9.0K (-4%) | 減碼 |
| ALGERT GLOBAL LLC | 185K | 2.9M | +5.2K (+3%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 183K | 2.9M | +3.9K (+2%) | 加碼 |
| JPMORGAN CHASE & CO | 173K | 2.9M | +32.2K (+23%) | 加碼 |
| HighMark Wealth Management LLC | 163K | 2.6M | +100K (+159%) | 加碼 |
| Russell Investments Group, Ltd. | 162K | 2.6M | −16.9K (-9%) | 減碼 |
| 德劭 D. E. Shaw & Co., Inc. | 161K | 2.6M | +117K (+269%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 113 +0 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 19 / 19 / 45 / 32 |
| 機構合計持股 · 佔流通股 | 26.6M · 77.4% |
| 合計季末市值 | 420M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 911K |
|---|---|
| 與上期比 | +7.8% |
| 佔流通股數 | 2.66% |
| 日均成交量 | 145K |
| 回補天數 | 6.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 911K | +7.8% | 2.66% | 145K | 6.3 |
| 2026-08-14 | 845K | +2.8% | 2.46% | 253K | 3.3 |
| 2026-07-31 | 822K | -6.0% | 2.40% | 209K | 3.9 |
| 2026-07-15 | 874K | -2.7% | 2.55% | 153K | 5.7 |
| 2026-06-30 | 899K | +46.6% | 2.62% | 229K | 3.9 |
| 2026-06-15 | 613K | +5.1% | 1.79% | 138K | 4.5 |
| 2026-05-29 | 583K | -5.0% | 1.70% | 149K | 3.9 |
| 2026-05-15 | 614K | -20.7% | 1.79% | 266K | 2.3 |
| 2026-04-30 | 774K | -15.6% | 2.25% | 164K | 4.7 |
| 2026-04-15 | 917K | -3.4% | 2.67% | 138K | 6.6 |
| 2026-03-31 | 949K | +1.1% | 2.76% | 226K | 4.2 |
| 2026-03-13 | 939K | +16.6% | 2.74% | 296K | 3.2 |
| 2026-02-27 | 805K | -7.4% | 2.35% | 137K | 5.9 |
| 2026-02-13 | 869K | +9.8% | 2.53% | 162K | 5.4 |
| 2026-01-30 | 792K | -11.4% | 2.31% | 139K | 5.7 |
| 2026-01-15 | 894K | +3.2% | 2.60% | 350K | 2.6 |
| 2025-12-31 | 866K | -7.5% | 2.52% | 185K | 4.7 |
| 2025-12-15 | 937K | -1.4% | 2.73% | 223K | 4.2 |
| 2025-11-28 | 950K | -4.3% | 2.77% | 277K | 3.4 |
| 2025-11-14 | 993K | +3.6% | 2.89% | 330K | 3.0 |
| 2025-10-31 | 958K | -11.6% | 2.79% | 123K | 7.8 |
| 2025-10-15 | 1.1M | -2.9% | 3.16% | 121K | 9.0 |
| 2025-09-30 | 1.1M | +18.1% | 3.25% | 182K | 6.1 |
| 2025-09-15 | 945K | -6.1% | 2.75% | 180K | 5.2 |
| 2025-08-29 | 1.0M | +0.9% | 2.93% | 201K | 5.0 |
| 2025-08-15 | 997K | -10.1% | 2.91% | 208K | 4.8 |